HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
Lihua Chen,1,2,* Binhua Dong,2,3,* Hangjing Gao,2,3 Huifeng Xue,4 Diling Pan,5 Pengming Sun1– 3 1Department of Gynecology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 2Fujian Provincial Key...
Guardado en:
Autores principales: | Chen L, Dong B, Gao H, Xue H, Pan D, Sun P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5bfb4c49d82d4e2696e69cc742745c8b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Federica Inturrisi, et al.
Publicado: (2021) -
E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester)
por: Xiong J, et al.
Publicado: (2021) -
A New HPV score System Predicts the Survival of Patients With Cervical Cancers
por: Qunchao Hu, et al.
Publicado: (2021) -
Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
por: Daniela Cochicho, et al.
Publicado: (2021) -
A case of HPV-53-related cervical cancer in an elderly patient
por: Lieveld M, et al.
Publicado: (2014)